Title : Dual irreversible kinase inhibitors: quinazoline-based inhibitors incorporating two independent reactive centers with each targeting different cysteine residues in the kinase domains of EGFR and VEGFR-2.

Pub. Date : 2007 Jun 1

PMID : 17416531






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Dual irreversible kinase inhibitors: quinazoline-based inhibitors incorporating two independent reactive centers with each targeting different cysteine residues in the kinase domains of EGFR and VEGFR-2. Quinazolines epidermal growth factor receptor Homo sapiens